Kymera Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Kymera Therapeutics Inc
TickerKYMR
CIK #0001815442
CUSIP501575104
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address300 Technology Square 2Nd Floor, Cambridge, MA 02139
Source [EDGAR]
CIK Filing 2011 - 2024
[0001815442] 10-K
[0001815442] 10-Q
[0001815442] 3
[0001815442] 4
[0001815442] 8-K
[0001815442] SC 13D
[0001815442] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Avoro Capital Advisors LLC Kymera Therapeutics Inc [2023-02-14] 7.0
Baker Bros Advisors LP Kymera Therapeutics Inc [2023-02-14] 5.2
State Street Corp Kymera Therapeutics Inc [2023-02-08] 5.19
Price T Rowe Associates Inc /MD/ Kymera Therapeutics Inc [2022-02-14] 6.9
Vanguard Group Inc Kymera Therapeutics Inc [2022-02-10] 5.75
Wellington Management Group LLP Kymera Therapeutics Inc [2022-02-04] 5.24
BlackRock Inc Kymera Therapeutics Inc [2022-02-04] 6.6
Atlas Venture Fund X LP Kymera Therapeutics Inc [2021-02-16] 17.9
Redmile Group LLC Kymera Therapeutics Inc [2021-02-16] 6.1
FMR LLC Kymera Therapeutics Inc [2021-02-08] 0.0
Vertex Pharmaceuticals Inc / Ma Kymera Therapeutics Inc [2020-09-03] 7.1
Biotechnology Value Fund L P Kymera Therapeutics Inc [2020-08-25] 3.1
Form 3/4/5 Filer 2011 - 2024
Jacobs Bruce N.
Kymera Therapeutics, Inc.
Chadwick Jeremy G
Gollob Jared
Mainolfi Nello
Caughey Elaine
Atlas Venture Associates Opportunity I, L.P.
Atlas Venture Associates Opportunity I, LLC
Atlas Venture Associates X LP
Atlas Venture Opportunity Fund I, L.P.
Atlas Venture Associates X, LLC
Atlas Venture Fund X, L.P.
Booth Bruce
Lampert Mark N
Biotechnology Value Trading Fund OS LP
BVF GP Holdings LLC
BVF II GP LLC
Biotechnology Value Fund II LP
BVF Partners OS Ltd.
BVF Inc/IL
BVF Partners L P/IL
BVF I GP LLC
Biotechnology Value Fund L P
Chiniara Ellen
Sandor Victor
Morgan Leigh
Ridloff Elena
Horobin Joanna
Albers Jeffrey W.
Esposito Pamela
Nicholson Donald William
Hrustanovic Gorjan
Maraganore John
Chesworth Richard
Hall Steven Edward
Wellington Biomedical Innovation Master Investors (Cayman) I
Green Jeremy
Redmile Group, LLC
Alexandria Venture Investments, LLC
Hedin Andrew
Form 13F Holdings
Firm Period DFND Voting Shares
Atlas Venture Life Science Advisors LLC [2023-03-31] SOLE 5,858,262.0 5,858,262.0
BVF Inc/IL [2023-03-31] DFND 0.0 4,739,004.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 826,824.0 4,611,560.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 4,291,018.0
Avoro Capital Advisors LLC [2023-03-31] SOLE 3,855,000.0 3,855,000.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 3,667,937.0
BlackRock Inc. [2023-03-31] SOLE 3,218,993.0 3,330,190.0
Baker Bros Advisors LP [2023-03-31] SOLE 2,879,825.0 2,879,825.0
State Street Corp [2023-03-31] DFND 2,654,065.0 2,726,825.0
Redmile Group LLC [2023-03-31] SOLE 2,410,769.0 2,410,769.0
T. Rowe Price Investment Management, Inc. [2023-03-31] SOLE 705,359.0 1,968,175.0
Artal Group S.A. [2023-03-31] DFND 1,805,346.0 1,805,346.0
Rock Springs Capital Management LP [2023-03-31] SOLE 1,228,379.0 1,228,379.0
Wasatch Advisors LP [2023-03-31] SOLE 912,492.0 1,037,414.0
Bank of New York Mellon Corp [2023-03-31] DFND 875,055.0 935,180.0
EcoR1 Capital LLC [2023-03-31] SOLE 796,093.0 796,093.0
Geode Capital Management LLC [2023-03-31] DFND 780,829.0 780,829.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 652,215.0 685,664.0
FMR LLC [2023-03-31] DFND 666,640.0 667,351.0
Deer Management Co LLC [2023-03-31] DFND 615,895.0 615,895.0
Aquilo Capital Management LLC [2023-03-31] SOLE 601,325.0 601,325.0
JPMorgan Chase & Co [2023-03-31] DFND 451,320.0 566,966.0
Candriam SCA [2023-03-31] SOLE 511,454.0 511,454.0
Barclays PLC [2023-03-31] SOLE 359,928.0 359,928.0
Massachusetts Financial Services Co /MA/ [2023-03-31] SOLE 339,147.0 339,147.0
Northern Trust Corp [2023-03-31] DFND 17,262.0 336,673.0
Morgan Stanley [2023-03-31] DFND 306,559.0 326,322.0
Susquehanna International Group LLP [2023-03-31] DFND 72,677.0 311,177.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 298,497.0 298,497.0
Goldman Sachs Group Inc [2023-03-31] DFND 296,796.0 296,843.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com